Microbe-based pharmaceutical agents
Client
-
PROJECT DELIVERY
ActoBio
-
2018
The client
ActoBio Therapeutics™ is pioneering a new class of safe, effective and easy-to-use treatments called ActoBiotics™ for autoimmune and allergic disorders based on the well-characterized food-grade bacterium Lactococcus lactis.
The challenge
ActoBio asked us to create a new brand identity and associated assets to communicate their scientific breakthroughs.
Dr. Pieter Rottiers
Our expertise
We carried out a full rebranding including a new logo & tagline, key visual and set of custom made icons and infographics that allow the ActoBio team to communicate their message in a compelling way. We then created various hard copy and digital communication assets including a new website with custom disease icons, a new PowerPoint template based on the new brand guidelines. We updated and redesigned all slides to fit., streamlining the copy and recreating various charts and figures from the raw scientific data to ensure consistency between the slides. We also provided Chinese translations of the presentation and factsheet.
Looking for communication support?
Prev
keyboard_arrow_left
Automated cell culture monitoring
Next
Together, we build medical products that matter
keyboard_arrow_right
